{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,18]],"date-time":"2025-06-18T19:40:01Z","timestamp":1750275601212,"version":"3.41.0"},"publisher-location":"New York, NY, USA","reference-count":28,"publisher":"ACM","license":[{"start":{"date-parts":[[2020,11,6]],"date-time":"2020-11-06T00:00:00Z","timestamp":1604620800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.acm.org\/publications\/policies\/copyright_policy#Background"}],"content-domain":{"domain":["dl.acm.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2020,11,6]]},"DOI":"10.1145\/3444884.3444899","type":"proceedings-article","created":{"date-parts":[[2021,3,31]],"date-time":"2021-03-31T19:08:06Z","timestamp":1617217686000},"page":"82-86","update-policy":"https:\/\/doi.org\/10.1145\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Role of Anti-M\u00fcllerian Hormone (AMH) in Regulating Hypothalamus-Pituitary Function"],"prefix":"10.1145","author":[{"given":"Bin","family":"Yan","sequence":"first","affiliation":[{"name":"China Medical University, China"}]}],"member":"320","published-online":{"date-parts":[[2021,3,31]]},"reference":[{"key":"e_1_3_2_1_1_1","doi-asserted-by":"crossref","unstructured":"Abbara A. P. C. Eng M. Phylactou S. A. Clarke T. Hunjan R. Roberts S. Vimalesvaran G. Christopoulos R. Islam K. Purugganan A. N. Comninos G. H. Trew R. Salim A. Hramyka L. Owens T. Kelsey and W. S. Dhillo. 2019. Anti-Mullerian hormone (AMH) in the Diagnosis of Menstrual Disturbance Due to Polycystic Ovarian Syndrome. Front Endocrinol (Lausanne)10:656.  Abbara A. P. C. Eng M. Phylactou S. A. Clarke T. Hunjan R. Roberts S. Vimalesvaran G. Christopoulos R. Islam K. Purugganan A. N. Comninos G. H. Trew R. Salim A. Hramyka L. Owens T. Kelsey and W. S. Dhillo. 2019. Anti-Mullerian hormone (AMH) in the Diagnosis of Menstrual Disturbance Due to Polycystic Ovarian Syndrome. Front Endocrinol (Lausanne)10:656.","DOI":"10.3389\/fendo.2019.00656"},{"key":"e_1_3_2_1_2_1","doi-asserted-by":"publisher","DOI":"10.1093\/humupd\/dmu020"},{"key":"e_1_3_2_1_3_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12958-018-0354-x"},{"key":"e_1_3_2_1_4_1","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms10055"},{"key":"e_1_3_2_1_5_1","doi-asserted-by":"publisher","DOI":"10.1093\/humupd\/dmt062"},{"key":"e_1_3_2_1_6_1","doi-asserted-by":"publisher","DOI":"10.1093\/humupd\/dmw027"},{"key":"e_1_3_2_1_7_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40618-016-0599-1"},{"key":"e_1_3_2_1_8_1","doi-asserted-by":"publisher","DOI":"10.1159\/000494890"},{"key":"e_1_3_2_1_9_1","doi-asserted-by":"publisher","DOI":"10.1038\/srep23790"},{"key":"e_1_3_2_1_10_1","doi-asserted-by":"publisher","DOI":"10.1093\/humrep\/deh098"},{"key":"e_1_3_2_1_11_1","doi-asserted-by":"publisher","DOI":"10.1210\/en.2018-00653"},{"key":"e_1_3_2_1_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.yfrne.2018.03.005"},{"key":"e_1_3_2_1_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.domaniend.2019.106432"},{"key":"e_1_3_2_1_14_1","doi-asserted-by":"crossref","unstructured":"Kereilwe O. K. Pandey V. Borromeo and H. Kadokawa. 2018. i-M\u00fcllerian hormone receptor type 2 is expressed in gonadotrophs of postpubertal heifers to control gonadotrophin secretion. Reproduction fertility and development 30 (9):1192-1203.  Kereilwe O. K. Pandey V. Borromeo and H. Kadokawa. 2018. i-M\u00fcllerian hormone receptor type 2 is expressed in gonadotrophs of postpubertal heifers to control gonadotrophin secretion. Reproduction fertility and development 30 (9):1192-1203.","DOI":"10.1071\/RD17377"},{"key":"e_1_3_2_1_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.rbmo.2018.05.011"},{"key":"e_1_3_2_1_16_1","doi-asserted-by":"crossref","unstructured":"Leite C. M. B. Kalil E. T. Uch\u00f4a J. Antunes-Rodrigues L. K. L. Elias J. E. Levine and J. A. Anselmo-Franci. 2016. Progesterone-induced amplification and advancement of GnRH\/LH surges are associated with changes in kisspeptin system in preoptic area of estradiol-primed female rats. Brain research 1650:21-30.  Leite C. M. B. Kalil E. T. Uch\u00f4a J. Antunes-Rodrigues L. K. L. Elias J. E. Levine and J. A. Anselmo-Franci. 2016. Progesterone-induced amplification and advancement of GnRH\/LH surges are associated with changes in kisspeptin system in preoptic area of estradiol-primed female rats. Brain research 1650:21-30.","DOI":"10.1016\/j.brainres.2016.08.021"},{"key":"e_1_3_2_1_17_1","doi-asserted-by":"publisher","DOI":"10.1093\/humrep\/det262"},{"key":"e_1_3_2_1_18_1","doi-asserted-by":"crossref","unstructured":"Malone S. A. G. E. Papadakis A. Messina N. E. H. Mimouni S. Trova M. Imbernon C. Allet I. Cimino J. Acierno D. Cassatella C. Xu R. Quinton G. Szinnai P. Pigny L. Alonso-Cotchico L. Masgrau J.-D. Mar\u00e9chal V. Prevot N. Pitteloud and P. Giacobini. 2019. Defective AMH signaling disrupts GnRH neuron development and function and contributes to hypogonadotropic hypoadism. eLife 8:e47198.  Malone S. A. G. E. Papadakis A. Messina N. E. H. Mimouni S. Trova M. Imbernon C. Allet I. Cimino J. Acierno D. Cassatella C. Xu R. Quinton G. Szinnai P. Pigny L. Alonso-Cotchico L. Masgrau J.-D. Mar\u00e9chal V. Prevot N. Pitteloud and P. Giacobini. 2019. Defective AMH signaling disrupts GnRH neuron development and function and contributes to hypogonadotropic hypoadism. eLife 8:e47198.","DOI":"10.7554\/eLife.47198"},{"key":"e_1_3_2_1_19_1","doi-asserted-by":"crossref","unstructured":"Prevot V. B. Dehouck A. Sharif P. Ciofi P. Giacobini and J. Clasadonte. 2018. The Versatile Tanycyte: A Hypothalamic Integrator of Reproduction and Energy Metabolism. Endocrine reviews 39 (3):333-368.  Prevot V. B. Dehouck A. Sharif P. Ciofi P. Giacobini and J. Clasadonte. 2018. The Versatile Tanycyte: A Hypothalamic Integrator of Reproduction and Energy Metabolism. Endocrine reviews 39 (3):333-368.","DOI":"10.1210\/er.2017-00235"},{"key":"e_1_3_2_1_20_1","doi-asserted-by":"publisher","DOI":"10.1210\/en.2019-00428"},{"key":"e_1_3_2_1_21_1","doi-asserted-by":"crossref","unstructured":"Silva M. S. M. Prescott and R. E. Campbell. 2018. Ontogeny and reversal of brain circuit abnormalities in a preclinl model of PCOS. JCI Insight 3 (7).  Silva M. S. M. Prescott and R. E. Campbell. 2018. Ontogeny and reversal of brain circuit abnormalities in a preclinl model of PCOS. JCI Insight 3 (7).","DOI":"10.1172\/jci.insight.99405"},{"key":"e_1_3_2_1_22_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-018-0035-5"},{"key":"e_1_3_2_1_23_1","volume-title":"Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome. Hum. Reprod. Published online","author":"Teede H.J.","year":"2018","unstructured":"Teede , H.J. ( 2018 ) Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome. Hum. Reprod. Published online July 19, 2018. http:\/\/dx.doi.org\/10.1093\/humrep\/dey256. 10.1093\/humrep Teede, H.J. (2018) Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome. Hum. Reprod. Published online July 19, 2018. http:\/\/dx.doi.org\/10.1093\/humrep\/dey256."},{"key":"e_1_3_2_1_24_1","unstructured":"Zawadzki \u00a0J.\u00a0K.\u00a0&\u00a0Dunaif \u00a0A.\u00a0in\u00a0Polycystic\u00a0Ovary\u00a0Syndrome\u00a0(eds\u00a0Dunaif \u00a0A. \u00a0Givens \u00a0J.\u00a0R. \u00a0Haseltine \u00a0F.\u00a0P.\u00a0&\u00a0Merriam\u00a0G.\u00a0R.)\u00a0377-384\u00a0(Blackwell\u00a0Scientific \u00a0Boston \u00a01992).  Zawadzki \u00a0J.\u00a0K.\u00a0&\u00a0Dunaif \u00a0A.\u00a0in\u00a0Polycystic\u00a0Ovary\u00a0Syndrome\u00a0(eds\u00a0Dunaif \u00a0A. \u00a0Givens \u00a0J.\u00a0R. \u00a0Haseltine \u00a0F.\u00a0P.\u00a0&\u00a0Merriam\u00a0G.\u00a0R.)\u00a0377-384\u00a0(Blackwell\u00a0Scientific \u00a0Boston \u00a01992)."},{"key":"e_1_3_2_1_25_1","doi-asserted-by":"crossref","unstructured":"Lizneva\u00a0D \u00a0Suturina\u00a0L \u00a0Walker\u00a0W \u00a0Brakta\u00a0S \u00a0Gavrilova-Jordan\u00a0L \u00a0Azziz\u00a0R.\u00a0Criteria \u00a0prevalence\u00a0and\u00a0phenotypes\u00a0of\u00a0polycystic\u00a0ovarian\u00a0syndrome.\u00a0Fertil\u00a0Steril\u00a02016;106:6\u201315.  Lizneva\u00a0D \u00a0Suturina\u00a0L \u00a0Walker\u00a0W \u00a0Brakta\u00a0S \u00a0Gavrilova-Jordan\u00a0L \u00a0Azziz\u00a0R.\u00a0Criteria \u00a0prevalence\u00a0and\u00a0phenotypes\u00a0of\u00a0polycystic\u00a0ovarian\u00a0syndrome.\u00a0Fertil\u00a0Steril\u00a02016;106:6\u201315.","DOI":"10.1016\/j.fertnstert.2016.05.003"},{"key":"e_1_3_2_1_26_1","doi-asserted-by":"crossref","unstructured":"No\u00a0authors\u00a0listed]\u00a0Revised\u00a02003\u00a0consensus\u00a0on\u00a0diagnostic\u00a0criteria\u00a0and\u00a0longterm\u00a0health\u00a0risks\u00a0related\u00a0to\u00a0polycystic\u00a0ovary\u00a0syndrome.\u00a0Fertil.\u00a0Steril.\u00a081 \u00a019\u201325\u00a0(2004).  No\u00a0authors\u00a0listed]\u00a0Revised\u00a02003\u00a0consensus\u00a0on\u00a0diagnostic\u00a0criteria\u00a0and\u00a0longterm\u00a0health\u00a0risks\u00a0related\u00a0to\u00a0polycystic\u00a0ovary\u00a0syndrome.\u00a0Fertil.\u00a0Steril.\u00a081 \u00a019\u201325\u00a0(2004).","DOI":"10.1016\/j.fertnstert.2003.10.004"},{"key":"e_1_3_2_1_27_1","first-page":"41","article-title":"consensus on diagnostic criteria and long-term health risksrelated to polycystic ovary syndrome (PCOS)","volume":"19","author":"No","year":"2003","unstructured":"No authors listed] Revised 2003 consensus on diagnostic criteria and long-term health risksrelated to polycystic ovary syndrome (PCOS) . Hum. Reprod. 19 , 41 \u2013 47 (2004). No authors listed] Revised 2003 consensus on diagnostic criteria and long-term health risksrelated to polycystic ovary syndrome (PCOS). Hum. Reprod. 19, 41\u201347 (2004).","journal-title":"Hum. Reprod."},{"key":"e_1_3_2_1_28_1","volume-title":"Positions statement: criteria for defining polycystic ovary syndrome as a predominantly hyperandrogenic syndrome:an Androgen Excess Society guideline. J. Clin. Endocrinol. Metab. 91, 4237\u20134245","author":"Azziz R.","year":"2006","unstructured":"Azziz , R. Positions statement: criteria for defining polycystic ovary syndrome as a predominantly hyperandrogenic syndrome:an Androgen Excess Society guideline. J. Clin. Endocrinol. Metab. 91, 4237\u20134245 ( 2006 ). Azziz, R. Positions statement: criteria for defining polycystic ovary syndrome as a predominantly hyperandrogenic syndrome:an Androgen Excess Society guideline. J. Clin. Endocrinol. Metab. 91, 4237\u20134245 (2006)."}],"event":{"name":"ICBBE '20: 2020 7th International Conference on Biomedical and Bioinformatics Engineering","acronym":"ICBBE '20","location":"Kyoto Japan"},"container-title":["2020 7th International Conference on Biomedical and Bioinformatics Engineering"],"original-title":[],"link":[{"URL":"https:\/\/dl.acm.org\/doi\/10.1145\/3444884.3444899","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/dl.acm.org\/doi\/pdf\/10.1145\/3444884.3444899","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,17]],"date-time":"2025-06-17T21:28:13Z","timestamp":1750195693000},"score":1,"resource":{"primary":{"URL":"https:\/\/dl.acm.org\/doi\/10.1145\/3444884.3444899"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11,6]]},"references-count":28,"alternative-id":["10.1145\/3444884.3444899","10.1145\/3444884"],"URL":"https:\/\/doi.org\/10.1145\/3444884.3444899","relation":{},"subject":[],"published":{"date-parts":[[2020,11,6]]},"assertion":[{"value":"2021-03-31","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}